Digoxin and 30-Day All-Cause Hospital Admission in Older Patients With Chronic Diastolic Heart Failure

American Journal of Medicine - United States
doi 10.1016/j.amjmed.2013.08.006
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Hospital TrackerIintegrated Built-In Risk Identification of 30-Day Hospital Re-Admission in Medicare Heart Failure Patients

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Strategies to Reduce 30-Day Readmissions in Older Patients Hospitalized With Heart Failure and Acute Myocardial Infarction

Current Geriatrics Reports
GerontologyGeriatrics
2014English

Hospital Nursing and 30-Day Readmissions Among Medicare Patients With Heart Failure, Acute Myocardial Infarction, and Pneumonia

Medical Care
EnvironmentalPublic HealthOccupational Health
2013English

Plasma Digoxin Concentrations in Patients on Admission to Hospital.

Heart
Cardiovascular MedicineCardiology
1974English

Correlation of Serum Chloride Levels With 30 Day Mortality in Heart Failure Patients

Journal of Evidence Based Medicine and Healthcare
2019English

Lack of Evidence of Lower 30-Day All-Cause Readmission in Medicare Beneficiaries With Heart Failure and Reduced Ejection Fraction Discharged on Spironolactone

International Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Predicting 7-Day, 30-Day and 60-Day All-Cause Unplanned Readmission: A Case Study of a Sydney Hospital

BMC Medical Informatics and Decision Making
Health PolicyHealth Informatics
2018English

Risk Factors Associated With 30‐day All‐cause Unplanned Hospital Readmissions at a Tertiary Children's Hospital in Western Australia

Journal of Paediatrics and Child Health
Child HealthPediatricsPerinatology
2019English

Digoxin Serum Levels in Patients With Chagas' Cardiomyopathy and Heart Failure

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy